Jeff Paulsen is Zimmer’s new Group President, Global Business. He is the former president of Stryker’s orthopedic reconstructive division.
Paulsen Returns to Orthopedics

He will have responsibility for Zimmer Spine, Zimmer Dental, Zimmer Trauma, and Zimmer Orthopaedic Surgical Products and will report to David Dvorak, Zimmer’s President and CEO. This appointment puts him in charge of all of Zimmer’s non-reconstructive product areas. Hips, knees, and extremities will continue to fall under Jeff McCaulley’s direction.
Paulsen was most recently the chief operating officer for MPS Group Inc., a privately held environmental services and facility management firm. He held the Stryker position from 1996 to 2006. He has also held management roles at Ford Motor Company, McDonnell Douglas Corporation, and TriMas Corporation.
A graduate of Michigan State University with a Bachelor of Arts in Marketing, Paulsen also holds an MBA from The Ohio State University.
Said Paulsen,
There is great promise in the markets where the Global Businesses Group operates, and I look forward to working with the teams in Spine, Trauma, Dental, and OSP to maximize that potential.
Dave Dvorak echoed Paulsen’s remarks in the announcement: “The markets that these businesses serve are expanding at attractive rates, and we have placed a strategic priority on accelerating our growth in these areas. Jeff has an outstanding record of executive leadership in medical devices, as well as in other industries, and we look forward to his contributions.”
Paulsen is also a former executive board member of Variety FAR Conservatory of Therapeutic and Performing Arts in Birmingham, Michigan. The group is a nonprofit organization that provides creative arts therapy and recreation services for children and adults with mental, physical and/or emotional impairments.
Welcome back to orthopedics Jeff.

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.